Skip to main content

Tirzepatide Injection Shortage

Last Updated: May 12, 2024
Status: Current

Products Affected - Description
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 10 mg/0.5 mL, pen injector, 4 count, NDC 00002-1471-80
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 12.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-1460-80
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 15 mg/0.5 mL, pen injector, 4 count, NDC 00002-1457-80
Reason for the Shortage
    • Lilly states the shortage is due to increased demand.
Available Products
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 2.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-1506-80
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 5 mg/0.5 mL, pen injector, 4 count, NDC 00002-1495-80
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 7.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-1484-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 10 mg/0.5 mL, pen injector, 4 count, NDC 00002-2471-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 12.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-2460-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 15 mg/0.5 mL, pen injector, 4 count, NDC 00002-2457-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 2.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-2506-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 5 mg/0.5 mL, pen injector, 4 count, NDC 00002-2495-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 7.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-2484-80

Estimated Resupply Dates

    • Lilly has Mounjaro 10 mg/0.5 mL, 12.5 mg/0.5 mL, and 15 mg/0.5 mL on intermittent back order and the company is releasing product as it becomes available.

Updated

Updated May 12, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created July 20, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer